Long‐Term Effectiveness of Once‐Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real‐World Study

Ähnliche Einträge

• Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts
  von: Gian Paolo Fadini, et al.
  Veröffentlicht: (2024)
• Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability
  von: Gian Paolo Fadini, et al.
  Veröffentlicht: (2026)
• Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data
  von: Gian Paolo Fadini, et al.
  Veröffentlicht: (2025)
• Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
  von: Mushood Ahmed, et al.
  Veröffentlicht: (2024)
• The importance of treatment sequencing with SGLT2 inhibitors and GLP ‐1 receptor agonists combination for kidney function preservation in type 2 diabetes
  von: Mario Luca Morieri, et al.
  Veröffentlicht: (2026)